RNAi抑制Snail表达对于胃癌细胞上皮—间充质转化以及体外侵袭的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的(1)观察Snail以及E-cadherin蛋白在胃癌组织中的表达及其与胃癌临床病理特征的关系;(2)探讨E-cadherin基因启动子在胃癌中的异常甲基化状态及其与临床病理资料的联系;(3)RNA干扰技术抑制转录因子Snail表达,观察人胃腺癌SGC-7901细胞上皮-间充质转分化表型和体外侵袭能力的影响;(4)建立稳定转染高表达绿色荧光蛋白(GFP)基因的胃癌细胞株并成功建立动物模型,为胃癌的生长及血管生成研究提供直接观察的必备条件。
     方法(1)应用免疫组织化学S-P法检测152例手术切除胃癌组织以及30例癌旁无瘤组织中Snail蛋白、E-cadherin蛋白的表达;(2)采用甲基化特异性聚合酶链反应(Methylation Specific-PCR,MSP)技术检测54例胃癌以及癌旁正常组织中E-cadherin基因启动子异常甲基化状态;(3)构建针对Snail的小干扰RNA的RNA干扰载体(Snail siRNA vector)和表达不针对任何已知mRNA的siRNA的阴性对照RNA干扰载体(control siRNA vector),分别转染SGC-7901细胞,筛选得到Snail表达受抑制的SGC-7901-siSnail细胞和Snail表达未受影响的SGC-7901-siControl细胞。,分别采用RT-PCR和Western blot技术检测SGC-7901-nontransfection、SGC-7901-siSnail、SGC-7901-siControl三组细胞中Snail、a-平滑肌肌动蛋白(a-SMA)和E-cadherin表达,用Boyden chamber模型检测细胞侵袭能力。(4)将携带GFPcDNA的质粒载体转染至胃癌细胞株SGC-7901内,经过G418筛选和克隆化培养,并种植于裸鼠皮下,用荧光显微镜检测癌细胞荧光表达情况。
     结果(1)Snail在胃癌组织的表达显著高于癌旁无瘤组织,其表达与分化程度、组织学类型、淋巴结转移以及临床分期有关(p<0.05),与性别、年龄、肿瘤大小无关(p>0.05);E-cadherin在胃癌组织表达显著低于癌旁无瘤组织,其表达与分化程度、组织学类型、淋巴结转移有关(p<0.05),与性别、年龄、肿瘤大小以及临床分期无关(p>0.05。(2)E-cad基因启动子异常甲基化在胃癌组织中发生频率分别为48.1%(26/54),与癌旁正常组织11.11%(6/54)具有显著性差异(p<0.05)。E-cad基因启动子异常甲基化频率与性别以及年龄无关;与分化程度、病理类型、浸润深度以及淋巴结转移等相关。(3)SGC-7901-si Snail组和未转染组相比,Snail和a-SMA表达显著减弱(p<0.01),E-cadherin表达显著增强(p<0.01),Boyden chamber穿膜细胞数显著减少(p<0.01);SGC-7901-siControl组Snail、a-SMA和E-cadherin表达及Boyden chamber穿膜细胞数和未转染组无显著差异(p>0.05)。(4)转染GFPcDNA的癌细胞3d后大部分死亡,荧光显微镜下有散在或小团状的点状荧光。继续用G418筛选及克隆化培养20d后,只剩一个高表达绿色荧光蛋白的细胞团,再经150d(50代)培养后仍高表达绿色荧光蛋白。将SGC-7901-GFP细胞株接种于裸鼠前肢皮下,荷瘤鼠生长良好。
     结论(1)E-cadherin蛋白低表达与Snail蛋白高表达可能是胃黏膜恶性转变以及胃癌发生浸润转移的重要生物学标志;联合检测E-cadherin蛋白与Snail蛋白对预测胃癌浸润转移有重要意义;(2)胃癌中存在E-cadherin基因启动子较高频率的异常甲基化,可能是E-cadherin表达缺失的原因之一;(3)通过RNA干扰阻滞Snail表达能有效地抑制SGC-7901细胞上皮-间充质转分化及体外侵袭能力。Snail可能在胃腺癌上皮-间充质转分化及侵袭过程中扮演重要角色,抑制Snail表达可能成胃腺癌治疗的可行策略;(4)SGC-7901-GFP细胞株的建立以及动物模型的成功建立有助于观察和了解肿瘤侵袭和转移发生及其规律,为下一步的实验做好准备。
Objective (1)To investigate the expression of Snail and E-cadherin protein in gastriccarcinoma and their relationship with clinical pathological features;(2) to investigate thefrequency of aberrant methylation of E-cadherin in gastric carcinoma;(3) to investigate theeffect of RNA interference (RNAi) targeting transcription factor Snail on epithelial-mesenchymal transition (EMT) and invasion ability of human gastric carcinoma cellSGC-7901 in vitro;(4) to study the establishment of stable high level green fluorescentprotein (GFP)-expressing cell line of gastric carcinoma and pass on its culture continuously.Methods (1)Snail and E-cadherin protein was detected in 152 gastric carcinoma and 30normal gastric tissues by using immunohistochemical method.(2) Aberrant methylationof E-cadherin was examined by methylation specific-PCR (MSP) in gastric carcinoma andnormal gastric tissues (n=54).(3) RNA interference plasmid that can express smallinterfering RNA (siRNA) targeting Snail (Snail siRNA vector) or express siRNA that doesnotmatch any known human coding mRNA (control siRNA vector)wasdesigned,constructed,and lipotransfected into SGC-7901 cell line.SGC-7901-siSnail cellsexpressing Snail suppressed or SGC-7901-si-Control cells expressing Snail uninfluencedwas selected by neomycin resistance.In SGC-7901-nontransfection,SGC-7901-siSnail andSGC-7901-siControl group SGC-7901 cells,Snail,alpha-smooth muscle actin (a-SMA)and E-cadherin expression were examined by reverse transcription-polymerase chainreaction (RT-PCR) and Western blot,invasion ability was examined by Boyden chambermodel.(4) SGC-7901 cell line of gastric carcinoma was transfected by plasma vector with integrated GFP cDNA.GFP-expressing cancer cells were detected by fluorescentmicroscopy through G418 selecting and cloned culture.
     Results (1) The expression of Snail protein in gastric carcinoma was significantlyhigher than that in normal gastric tissues (p<0.05);Expression level of Snail wassignificantly related to differential degree、histology type、clinical stage、lymph nodemetastasis,but not correlate with sex、age、tumour size.The expression of E-cadherinprotein in gastric carcinoma was significantly lower than that in normal gastric tissues(p<0.05);Expression level of E-cadherin was significantly related to differential degree、histology type、lymph node metastasis and but not correlate with sex、age、tumour size、clinical stage.(2) Aberrant methylation of E-cadherin was present in 48.1%(26/54) and11.11%(6/54) in gastric carcinoma and normal gastric tissues respectively.There wassignificant difference between gastric carcinoma and normal gastric tissues group.Therewas significant correlation between E-cadherin methylation frequencies and pathology type,clinical staging,depth of tumour invasion and lymphatic metastasis.No significantassociation was found between E-cadherin methylation frequencies and sex,age.(3)SGC-7901-nontransfection group:Both Snail and a-SMA expression were strong positive,but E-cadherin expression was poor positive.SGC-7901-si Snail group Compared with thatin SGC-7901-nontransfection group,Snail and a - SMA expression,and the numbers ofSGC-7901 cells permeating septum of Boyden chamber were decreased,but E-cadherinexpression increased significantly (p<0.01).SGC-7901-si Control group:Compared withthat in SGC-7901- nontransfection group,Snail,a-SMA and E-cadherin expression,andNCS were similar.(4) Most of the cancer cells were dead 5 days after being transfected byGFP,scattered or clustered green fluorescence can be seen by microscopy.In culture for 65days,almost all of the clone 2-8 cells expressed high-intensity GFP fluorescence andstability.
     Conclusions (1)E-cadherin and overexpression of Snail might be impomalignanttransformation and invasion and matastasiscombined detection of E-cadherinherin and Snail has positiinvasion and metastasis in gastric carcinoma.(2) Methylation of E-cadherinmay play a role in the pathogenesis of gastric carcinoma.(3) RNAi targeting Snail caninhibit EMT and invasion of SGC-7901 cells efficiently in vitro.Snail might play a crucialrole in EMT and invasion of lung carcinoma and suppression of Snail expression might bea promising strategy for the treatment of human lung carcinoma.(4)SGC-7901-GFP cellline can provide a basis for establishing an ideal animal model for research of tumorinvasion and metastasis.
引文
1.Berardi R,Scartozzi M,Romagnoli E,Antognoli S,Cascinu S:Gastric cancer treatment:A systematic review.Oncol Rep 2004;11:911-916.
    2.师雷锋:胃癌免疫与基因治疗进展.河南预防医学杂志.2007;18(1):15-17.
    3.Katoh M:Pharmacogenomics on gastric cancer.Cancer Biol Ther 2004;3:566-567.
    4.Christofori G:New signals from the invasive front.Nature 2006;441:444-450.
    5.Huber MA,Kraut N,Beug H:Molecular requirements for epithelial-mesenchymal transition during tumor progression.Curr Opin Cell Biol 2005;17:548-558.
    6.Ng YY,Huang TP,Yang WC,Chen ZP,Yang AH,Mu W,Nikolic-Paterson D J,Atkins RC,Lan HY:Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.Kidney Int 1998;54:864-876.
    7.Takeichi M:The cadherins:Cell-cell adhesion molecules controlling animal morphogenesis.Development 1988;102:639-655.
    1. Christofori G: New signals from the invasive front. Nature 2006;441:444-450.
    2. Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17:548-558.
    3. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998;54:864-876.
    4. Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S: Gastric cancer treatment: A systematic review. Oncol Rep 2004;ll:911-916.
    5. Katoh M: Pharmacogenomics on gastric cancer. Cancer Biol Ther 2004;3:566-567.
    6. Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M: Loss of ap-2alpha results in deregulation of e-cadherin and mmp-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 2007;26:4049-4058.
    7. Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C,Bartella V, Casaburi I, Ando S: Evidences that leptin up-regulates e-cadherin expression in breast cancer: Effects on tumor growth and progression. Cancer Res 2007;67:3412-3421.
    8. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
    9. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G:Prognostic value of e-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996;69:184-189.
    10. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF:Differential expression of the epithelial-mesenchymal transition regulators snail, sip1,and twist in gastric cancer. Am J Pathol 2002;161:1881-1891.
    11.Sugimachi K,Tanaka S,Kameyama T,Taguchi K,Aishima S,Shimada M,Tsuneyoshi M:Transcriptional repressor snail and progression of human hepatocellular carcinoma.Clin Cancer Res 2003;9:2657-2664.
    12.Bilder D:Epithelial polarity and proliferation control:Links from the drosophila neoplastic tumor suppressors.Genes Dev 2004;18:1909-1925.
    13.Perez-Moreno M,Jamora C,Fuchs E:Sticky business:Orchestrating cellular signals at adherens junctions.Cell 2003;112:535-548.
    14.Kremmidiotis G,Baker E,Crawford J,Eyre HJ,Nahmias J,Callen DF:Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.Genomics 1998;49:467-471.
    15.Birchmeier W,Behrens J:Cadherin expression in carcinomas:Role in the formation of cell junctions and the prevention of invasiveness.Biochim Biophys Acta 1994;1198:11-26.
    16.Yokoyama K,Kamata N,Hayashi E,Hoteiya T,Ueda N,Fujimoto R,Nagayama M: Reverse correlation of e-cadherin and snail expression in oral squamous cell carcinoma cells in vitro.Oral Oncol 2001;37:65-71.
    17.Poser I,Dominguez D,de Herreros AG,Varnai A,Buettner R,Bosserhoff AK:Loss of e-cadherin expression in melanoma ceils involves up-regulation of the transcriptional repressor snail.J Biol Chem 2001;276:24661-24666.
    18.金鸿雁,丰有吉.反义Snail转录因子抑制卵巢癌转移的实验研究.中华妇产科杂志,2005:40(6):400-403
    1.Baylin SB,Herman JG:DNA hypermethylation in tumorigenesis:Epigenetics joins genetics.Trends Genet 2000;16:168-174.
    2.Frixen UH,Behrens J,Sachs M,Eberle G,Voss B,Warda A,Lochner D,Birchmeier W:E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.J Cell Biol 1991;113:173-185.
    3.Tamura G,Yin J,Wang S,Fleisher AS,Zou T,Abraham JM,Kong D,Smolinski KN,Wilson KT,James SP,Silverberg SG,Nishizuka S,Terashima M,Motoyama T,Meltzer SJ:E-cadherin gene promoter hypermethylation in primary human gastric carcinomas.J Natl Cancer Inst 2000;92:569-573.
    4.Herman JG,Graff JR,Myohanen S,Nelkin BD,Baylin SB:Methylation-specific pcr:A novel pcr assay for methylation status of cpg islands.Proc Natl Acad Sci U S A 1996;93:9821-9826.
    5.Bilder D:Epithelial polarity and proliferation control:Links from the drosophila neoplastic tumor suppressors.Genes Dev 2004;18:1909-1925.
    6.Perez-Moreno M,Jamora C,Fuchs E:Sticky business:Orchestrating cellular signals at adherens junctions.Cell 2003;112:535-548.
    7.Kremmidiotis G,Baker E,Crawford J,Eyre HJ,Nahmias J,Callen DF:Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.Genomics 1998;49:467-471.
    8.Guilford P,Hopkins J,Harraway J,McLeod M,McLeod N,Harawira P,Taite H,Scoular R,Miller A,Reeve AE:E-cadherin germline mutations in familial gastric cancer.Nature 1998;392:402-405.
    9.Yoshiura K,Kanai Y,Ochiai A,Shimoyama Y,Sugimura T,Hirohashi S:Silencing of the e-cadherin invasion-suppressor gene by cpg methylation in human carcinomas.Proc Natl Acad Sci U S A 1995;92:7416-7419.
    10.赵英芳,田新霞,丁鑫.胃癌中E-cadherin基因5’端CpG岛甲基化研究。包头医学院学报,3005,21(1):7-9
    1. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci. 2005;118(Pt 19):4325-4326.
    2. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3(3): 155-166.
    3. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415-428.
    4. Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P.Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res.2006;12(18):5395-5402.
    5. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, Reich R,Davidson B. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005; 103(8):1631-1643.
    6. Roy HK, Kunte DP, Koetsier JL, Hart J, Kim YL, Liu Y, Bissonnette M, Goldberg M,Backman V, Wali RK. Chemoprevention of colon carcinogenesis by polyethylene glycol: suppression of epithelial proliferation via modulation of SNAIL/beta-catenin signaling. Mol Cancer Ther. 2006;5(8):2060-2069.
    7. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer. 2004;90(6):1265-1273.
    8. Natsugoe S, Uchikado Y, Okumura H, Matsumoto M, Setoyama T, Tamotsu K, Kita Y,Sakamoto A, Owaki T, Ishigami S, Aikou T. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep. 2007;17(3): 517-523.
    9. Saito T, Oda Y, Kawaguchi K, Sugimachi K, Yamamoto H, Tateishi N, Tanaka K,Matsuda S, Iwamoto Y, Ladanyi M, Tsuneyoshi M. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma. Oncogene. 2004;23(53):8629-8638.
    10. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn MA,Cantley LC, Gygi SP. Large-scale characterization of HeLa cell nuclear phosphoproteins.Proc Natl Sci U S A. 2004;101(33):12130-12135.
    11. Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N, Iwata KK, Gibson N,Haley JD. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005;65(20):9455-9462.
    12. Yang D, Lu H, Hong Y, Jinks TM, Estes PA, Erickson JW. Interpretation of X chromosome dose at Sex-lethal requires non-E-box sites for the basic helix-loop-helix proteins SISB and daughterless. Mol Cell Biol. 2001;21(5):1581-1592.
    13. Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 2005;118(Pt 15):3371-3385.
    14. Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PD kinase/Akt signal pathway. Biochem Biophys Res Commun. 2007;353(2):337-343.
    15. Tseng CF, Fu YC, Fu LS, Betau H, Chi CS. Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi (Taipei). 2001;64(3):168-173.
    1. Suzuki K,Hayashi N,Miyamoto Y,et al.Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma[J].Cancer Res,1996,56(13):3004-3009.
    2. Arii S,Mise M,Harada T,et al. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential[J].Hepatology,1996,24(2): 316-322.
    3. Zhu D, Cheng CF, Pauli BU. Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis [J].J Clin Invest,1992,89(6):1718-1724.
    4. Horellou P, Mallet J.Gene therapy for Parkinson's disease[J].Mol Neurobiol,1997,15(2):241-256. Review.
    5. Lin WC, Pretlow TP, Pretlow TG 2nd, et al. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression[J].Cancer Res,1990,50(9): 2808-2817.
    6. Margolis LB, Glushakova SE, Baibakov BA,et al. Confocal microscopy of cells implanted into tissue blocks: cell migration in long-term histocultures[J]. In Vitro Cell Dev Biol,1995,31(3): 221-226.
    7. Shioda T, Munn LL, Fenner MH, et al. Early events of metastasis in the microcirculation involve changes in gene expression of cancer cell[J]. Am J Pathol,1997,150(6): 2099-2112.
    8. Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression[J]. Science,1994,63(5148):802-805.
    1. Ando S,Otani H,Yaqi Y,et al.Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells[J].Respir Res,2007,8(1):31-44.
    2. Bellovin DI,Simpson KJ,Danilov T,et al.receprocal reglation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma [J]. Oncogene, 2006, 5 (52):6959-6967.
    3. Gotzmann J.Hepatocytes convert to a fibroblastoid phenotype through the cooperation of 1-betal and Ha-Ras:steps towards invasiveness[J].J Cell Sci.2002,115(Pt6):1189-1202.
    4. Thiery JP.Epithelial-mesenchymal transitions in development and pathologies[J].Cur Opin Cell Bio,2003,15(6):740-746.
    5. Kalluri R,Neilson EGEpithelial-mesenchymal transition and its implications for fibrosis[J]. J Clin Invest, 2003,112(12)1776-1784.
    6. Yang J,Dai C,Liu Y,et al.A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal Transition[J].Cell Biology,2005,16(l):68-78.
    7. Kim JH,Yang Ys,Es KS,et al.Transforming growth factor betall induces epithelial-to-mesenchymal transition of A549 cells[J].Korean mecical science,2007,22(5):898-904.
    8. Dissanayake SK,Wade M,Johoson CE,et al.The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition[J].J Biol Chem,2007,282(23):17259-17271.
    9. Vasko V,Espinosa AV,Scouten W,et al.Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion[J].Proc Natl Acad Sci USA,2007,104(8):2803-2808.
    10.Jechlinger M,Grunert S,Tamir IH,et al.Expression profiling of epithelial plasticity in tumor progression[J].Oncogene 2003,22(46):7155-7169.
    11.Jethwa P,Naquvi M,Hardy RG,et al.Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma[J].World J Gastroentrol,2008,14 (7):1044-1052.
    12.Ohkubo t,Ozawa M.The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation[J].Cell Sci,2004,117(Pt9): 1675-1685.
    13.Sandra Guaita,Isabel Puig,Clar Franci,et al.Snail Introduction of Epithelial to Mesenchymal Transition in Tumor Cells is Accompanied by MUC1 Repression and ZEB1 expression[J].Biol Chem,2002,277(42):39209-39216.
    14.Miyoshi aA,Kitajima Y,Sumi K,et al.Snail and SIPI incerase cancer invasion by upregulation MMP family in hepatocellular carcinoma cells[J].Br J Cancer,2004,90 (6):1265-1273.
    15.Miyoshi aA,Kitajima Y,Kido S,et al.Snail accelerates cancer invasion by upregulating MMP expresition and is associated with poor prognosis of hepatocellular carcinoma [J].Br J Cancer,2005,92(2):252-258.
    16.Takeichi M.Morphogenetic roles of classic cadherins[J].Curr Opin Cell Bio1,1995,7(5): 619-627.
    17.Hazan RB,Phillips GR,Qiao RF,et al.Exogenous expression of N-cadherin in breast cancer induces cell migration,invasion and metastasis[J].Cell Biol,2000,148(4): 779-790.
    18.殷涛,王春友,赵刚,等.转化生长因子-β1诱导的上皮向间叶转化对胰腺癌侵袭和转移的意义[J]华中科技大学学报,2007,36(1):67-70.
    19.封明轩,骆明德,费哲为等.TGF-β1长期诱导胰腺癌细胞发生上皮间质变而增加其侵袭性[J].Modem Oncology,2007,15(6):766-768.
    20.Yang J,Liu Y.Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis[J].Am J Pathol,2001,159(4):1464- 1475.
    21.Peter ten Dijke,Caroline S.Hill.New insights into TGF-β smad signaling[J].Trends Biochem Sci,2004,29(5):265-273.
    22.Giles RH,van Es JH,Clevers H.Caught up in a Wnt storm:Wnt signaling in cancer[J].Biochim Biophys Acta,2003,1653(1):1-24.
    23.Wong NA,Pignatelli M.Beta-catenin-a linchpin in colorectal carcinogenesis[J]?Am J Pathol,2002,160(2):389-401.
    24.李伟,辛殿祺,郭应禄.前列腺PC-3细胞中Wnt信号通路与TGF-β信号通路相互调节[J].中华泌尿外科杂志,2006,27(4):59-62.
    25.Yang J,Mani SA,Donaher JL,et al.Twist,a master regulation of morphogenesis,plays an essential role in tumor metastasis[J].Cell,2004,117(7):927-939.
    26.Rosan(?)L,Spinella F,Di Castro V,et al.Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells[J].Cancer Res,2005,65(24): 11649-11657.
    27.Hannigan G,Troussard AA,Dedhar S.Integrin-linked kinase:a cancer therapeutic target unique among its ILK[J].Nat Rev Cancer,2005,5(1):51-63.
    28.王继英,饶青.RHO蛋白与细胞极性[J].细胞生物学杂志,2008,30(1):45-49.
    29.Thiery JP.Epithelial-mesenchymal transitions in development and pathologies[J].Curr Opin Cell Biol,2003,15(6):740-746.
    30.Psichari E,Balmain A,Plows D,et al.High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling[J].Biol Chem,2002,277(33):29490-29495.
    31.Benitah SA,Valer(?)n PF,Hallgeir Rui,et al.STAT5a activation mediates the epithelialto-mesenchymal transition induced by incogenic RhoA[J].Mol Biol Cell,2003,14(1): 40-53.
    32.Bellovin DI,Simpson KJ,Danilov T,et al.Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma [J].Oncogene,2006,25(52):6959-6967.
    33.Kuroda S,Fukata M,Nakagawa M,et al.Role of IQGAP1,a target of the small GTPases Cdc42 and Rac1,in regulation of E-cadherin-mediated cell-cell adhesion[J].Science,1998,281(7):832-835.
    34.Muschel RJ,Gal A.Tetraspanin in oncogenic epithelial-mesenchymal transition[J].Clin Invest,2008,118(4):1347-1350.
    35.Lee SA,Lee SY,Cho IH,et al.Tetraspamin TM4SF5 mediates loss of contant inhibition through epithelial-mesenchymal transition in human hepatocarcinoma[J].Clin Invest,2008,118(4):1354-1366.
    36.Robin D.Lester,Minji Jo,Val(?)rie Montel,et al.uPAR induces epithelial-mesenchymal transitionin inhypoxic breast cancer cells[J].Cell Biology,2007,178(3):425-436.
    37.Lee JW,Bae SH,Jeong JW,et al.Hypoxia-inducible factor(HIF-1)alpha:its protein stability and biological functions[J].Exp Mol Med,2004,36(1):1-12.
    38.Semenza GL.Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721- 732.
    39.Yang MH,Wu MZ,Chiou SH,et al.Direct regulation of TWIST by HIF-lapromotes metastasis[J].Nature Cell Biology,2008,10(3):295-305.
    40.Pennacchietti S,Michieli P,Galluzzo M,et al.Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene[J].Cancer Cell,2003,3(4):347-361.
    41.芦曙辉,王玉琦.细胞迁移机制的研究进展.中国临床医学.2003,6(10):801-803.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700